Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII

Hiller O, Lichte A, Oberpichler A, Kocourek A, Tschesche H (2000)

Zeitschriftenaufsatz | Veröffentlicht | Englisch
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Hiller, O; Lichte, A; Oberpichler, A; Kocourek, A; Tschesche, HaraldUniBi
Abstract / Bemerkung
The effects of plasma proteins on controlling the activity of matrix metalloproteinases (MMPs, matrixins) have been the focus of numerous studies, although only a few have examined the influence of matrixins on plasma proteins. Recently, it has been shown that MMPs may play a role in the degradation of fibrin, We have now investigated the role of collagenase-a (MMP-8), macrophage elastase (MMP-12), collagenase-3 (MMP-13), and membrane type 1-matrix metalloproteinase (MT1-MMP, MMMP-14) in the degradation of fibrinogen and Factor XII of the plasma clotting system. Our data demonstrate that the catalytic domains of MMP-8, MMP-12, MMP-13, and MMP-14 can proteolytically process fibrinogen and, with the exception of MMP-8, also inactivate Factor XII (Hageman factor). We have identified the amino termini of the major protein fragments. Cleavage of fibrinogen occurred in all chains and resulted in significantly impaired clotting. Moreover, rapid proteolytic inactivation of Factor XII (Hageman factor) by MMP-18, MMP-13, and MMP-14 was noted. These results support the hypothesis of an impaired thrombolytic potential of MMP-degraded Factor MI in vivo. MMP-induced degradation of fibrinogen supports a plasmin-independent fibrinolysis mechanism. Consequently, degradation of these proteins may be important in inflammation, atherosclerosis, and angiogenesis, all of which are known to be influenced by MMP activity.
Page URI


Hiller O, Lichte A, Oberpichler A, Kocourek A, Tschesche H. Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. JOURNAL OF BIOLOGICAL CHEMISTRY. 2000;275(42):33008-33013.
Hiller, O., Lichte, A., Oberpichler, A., Kocourek, A., & Tschesche, H. (2000). Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. JOURNAL OF BIOLOGICAL CHEMISTRY, 275(42), 33008-33013.
Hiller, O., Lichte, A., Oberpichler, A., Kocourek, A., and Tschesche, H. (2000). Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. JOURNAL OF BIOLOGICAL CHEMISTRY 275, 33008-33013.
Hiller, O., et al., 2000. Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. JOURNAL OF BIOLOGICAL CHEMISTRY, 275(42), p 33008-33013.
O. Hiller, et al., “Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII”, JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 275, 2000, pp. 33008-33013.
Hiller, O., Lichte, A., Oberpichler, A., Kocourek, A., Tschesche, H.: Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. JOURNAL OF BIOLOGICAL CHEMISTRY. 275, 33008-33013 (2000).
Hiller, O, Lichte, A, Oberpichler, A, Kocourek, A, and Tschesche, Harald. “Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII”. JOURNAL OF BIOLOGICAL CHEMISTRY 275.42 (2000): 33008-33013.

62 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

MMP-9/Gelatinase B Degrades Immune Complexes in Systemic Lupus Erythematosus.
Ugarte-Berzal E, Boon L, Martens E, Rybakin V, Blockmans D, Vandooren J, Proost P, Opdenakker G., Front Immunol 10(), 2019
PMID: 30967870
Targeting matrix metalloproteinase-13 in bronchial epithelial repair.
Howell C, Smith JR, Shute JK., Clin Exp Allergy 48(9), 2018
PMID: 29924890
Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.
Isaacson KJ, Martin Jensen M, Subrahmanyam NB, Ghandehari H., J Control Release 259(), 2017
PMID: 28153760
Orthodontic tensile strain induces angiogenesis via type IV collagen degradation by matrix metalloproteinase-12.
Narimiya T, Wada S, Kanzaki H, Ishikawa M, Tsuge A, Yamaguchi Y, Nakamura Y., J Periodontal Res 52(5), 2017
PMID: 28393366
Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.
Lindsey ML, Iyer RP, Jung M, DeLeon-Pennell KY, Ma Y., J Mol Cell Cardiol 91(), 2016
PMID: 26721597
Systemic matrix metalloproteinase-8 and tissue inhibitor of metalloproteinases-1 levels in severe sepsis-associated coagulopathy.
Sivula M, Hästbacka J, Kuitunen A, Lassila R, Tervahartiala T, Sorsa T, Pettilä V., Acta Anaesthesiol Scand 59(2), 2015
PMID: 25329743
Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms.
Vacek TP, Rehman S, Neamtu D, Yu S, Givimani S, Tyagi SC., Vasc Health Risk Manag 11(), 2015
PMID: 25767394
Enhanced expression of matrix metalloproteinase-12 contributes to Npc1 deficiency-induced axonal degeneration.
Liao G, Wang Z, Lee E, Moreno S, Abuelnasr O, Baudry M, Bi X., Exp Neurol 269(), 2015
PMID: 25864931
Combinatorial Screening Identifies Novel Promiscuous Matrix Metalloproteinase Activities that Lead to Inhibition of the Therapeutic Target IL-13.
Urbach C, Gordon NC, Strickland I, Lowne D, Joberty-Candotti C, May R, Herath A, Hijnen D, Thijs JL, Bruijnzeel-Koomen CA, Minter RR, Hollfelder F, Jermutus L., Chem Biol 22(11), 2015
PMID: 26548614
Expression of modulators of extracellular matrix structure after anterior cruciate ligament injury.
Haslauer CM, Proffen BL, Johnson VM, Murray MM., Wound Repair Regen 22(1), 2014
PMID: 24393158
The multifunctional role of the pallilysin-associated Treponema pallidum protein, Tp0750, in promoting fibrinolysis and extracellular matrix component degradation.
Houston S, Russell S, Hof R, Roberts AK, Cullen P, Irvine K, Smith DS, Borchers CH, Tonkin ML, Boulanger MJ, Cameron CE., Mol Microbiol 91(3), 2014
PMID: 24303899
Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy.
Heger M, van Golen RF, Broekgaarden M, van den Bos RR, Neumann HA, van Gulik TM, van Gemert MJ., Lasers Med Sci 29(2), 2014
PMID: 24232911
Novel osteoinductive photo-cross-linkable chitosan-lactide-fibrinogen hydrogels enhance bone regeneration in critical size segmental bone defects.
Kim S, Bedigrew K, Guda T, Maloney WJ, Park S, Wenke JC, Yang YP., Acta Biomater 10(12), 2014
PMID: 25174669
Expression of MMP-9 in hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
Yu XZ, Ji T, Bai XL, Liang L, Wang LY, Chen W, Liang TB., J Zhejiang Univ Sci B 14(1), 2013
PMID: 23303633
Assessment of the matrix degenerative effects of MMP-3, ADAMTS-4, and HTRA1, injected into a bovine intervertebral disc organ culture model.
Furtwängler T, Chan SC, Bahrenberg G, Richards PJ, Gantenbein-Ritter B., Spine (Phila Pa 1976) 38(22), 2013
PMID: 23778376
Complement 3 is involved with ventilator-induced lung injury.
Takahashi K, Saha D, Shattino I, Pavlov VI, Stahl GL, Finnegan P, Melo MF., Int Immunopharmacol 11(12), 2011
PMID: 21979496
Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.
Orbe J, Barrenetxe J, Rodriguez JA, Vivien D, Orset C, Parks WC, Birkland TP, Serrano R, Purroy A, Martinez de Lizarrondo S, Angles-Cano E, Páramo JA., Circulation 124(25), 2011
PMID: 22104553
Rapid analysis of matrix metalloproteinase-3 activity by gelatin arrays using a spectral surface plasmon resonance biosensor.
Jung SH, Kong DH, Park JH, Lee ST, Hyun J, Kim YM, Ha KS., Analyst 135(5), 2010
PMID: 20419256
Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis.
Ling XB, Lau K, Deshpande C, Park JL, Milojevic D, Macaubas C, Xiao C, Lopez-Avila V, Kanegaye J, Burns JC, Cohen H, Schilling J, Mellins ED., Clin Proteomics 6(4), 2010
PMID: 21124648
Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes.
Kwan Tat S, Pelletier JP, Amiable N, Boileau C, Lavigne M, Martel-Pelletier J., Arthritis Res Ther 11(4), 2009
PMID: 19664212
Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis.
Kwan Tat S, Amiable N, Pelletier JP, Boileau C, Lajeunesse D, Duval N, Martel-Pelletier J., Rheumatology (Oxford) 48(12), 2009
PMID: 19762475
Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis.
Barbolina MV, Stack MS., Semin Cell Dev Biol 19(1), 2008
PMID: 17702616
Aldosterone modifies hemostasis via upregulation of the protein-C receptor in human vascular endothelium.
Ducros E, Berthaut A, Mirshahi SS, Faussat AM, Soria J, Agarwal MK, Mirshahi M., Biochem Biophys Res Commun 373(2), 2008
PMID: 18555797
Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins.
Piccard H, Van den Steen PE, Opdenakker G., J Leukoc Biol 81(4), 2007
PMID: 17185359
Integrin alphavbeta6 mediates HT29-D4 cell adhesion to MMP-processed fibrinogen in the presence of Mn2+.
Fouchier F, Penel C, Pierre Montero M, Bremond P, Champion S., Eur J Cell Biol 86(3), 2007
PMID: 17275949
Modulation of the proteolytic activity of matrix metalloproteinase-2 (gelatinase A) on fibrinogen.
Monaco S, Gioia M, Rodriguez J, Fasciglione GF, Di Pierro D, Lupidi G, Krippahl L, Marini S, Coletta M., Biochem J 402(3), 2007
PMID: 17087661
A biodegradable copolymer for the slow release of growth hormone expedites scarring in diabetic rats.
García-Esteo F, Pascual G, Gallardo A, San-Román J, Buján J, Bellón JM., J Biomed Mater Res B Appl Biomater 81(2), 2007
PMID: 16969827
Decorin synthesized by arterial smooth muscle cells is retained in fibrin gels and modulates fibrin contraction.
Johnson PY, Potter-Perigo S, Gooden MD, Vernon RB, Wight TN., J Cell Biochem 101(2), 2007
PMID: 17226774
Do low-molecular-weight heparins influence the healing process in colon anastomosis?
Krzesniak-Wszola N, Bielecki K, Ostrowski J., Colorectal Dis 9(6), 2007
PMID: 17573740
Tumor stroma and regulation of cancer development.
Tlsty TD, Coussens LM., Annu Rev Pathol 1(), 2006
PMID: 18039110
Cleavage of amyloid-beta precursor protein (APP) by membrane-type matrix metalloproteinases.
Ahmad M, Takino T, Miyamori H, Yoshizaki T, Furukawa M, Sato H., J Biochem 139(3), 2006
PMID: 16567416
Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
Lund LR, Green KA, Stoop AA, Ploug M, Almholt K, Lilla J, Nielsen BS, Christensen IJ, Craik CS, Werb Z, Danø K, Rømer J., EMBO J 25(12), 2006
PMID: 16763560
Identification in human osteoarthritic chondrocytes of proteins binding to the novel regulatory site AGRE in the human matrix metalloprotease 13 proximal promoter.
Fan Z, Tardif G, Boileau C, Bidwell JP, Geng C, Hum D, Watson A, Pelletier JP, Lavigne M, Martel-Pelletier J., Arthritis Rheum 54(8), 2006
PMID: 16868967
Neurite extension and in vitro myelination within three-dimensional modified fibrin matrices.
Pittier R, Sauthier F, Hubbell JA, Hall H., J Neurobiol 63(1), 2005
PMID: 15616962
Reduction of arthritis severity in protease-activated receptor-deficient mice.
Yang YH, Hall P, Little CB, Fosang AJ, Milenkovski G, Santos L, Xue J, Tipping P, Morand EF., Arthritis Rheum 52(4), 2005
PMID: 15818676
Matrix metalloproteinase-12 (MMP-12) in osteoclasts: new lesson on the involvement of MMPs in bone resorption.
Hou P, Troen T, Ovejero MC, Kirkegaard T, Andersen TL, Byrjalsen I, Ferreras M, Sato T, Shapiro SD, Foged NT, Delaissé JM., Bone 34(1), 2004
PMID: 14751561
Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice.
Sukhova GK, Zhang Y, Pan JH, Wada Y, Yamamoto T, Naito M, Kodama T, Tsimikas S, Witztum JL, Lu ML, Sakara Y, Chin MT, Libby P, Shi GP., J Clin Invest 111(6), 2003
PMID: 12639996
Cleavage of metastasis suppressor gene product KiSS-1 protein/metastin by matrix metalloproteinases.
Takino T, Koshikawa N, Miyamori H, Tanaka M, Sasaki T, Okada Y, Seiki M, Sato H., Oncogene 22(30), 2003
PMID: 12879005
Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells.
Rolli M, Fransvea E, Pilch J, Saven A, Felding-Habermann B., Proc Natl Acad Sci U S A 100(16), 2003
PMID: 12874388
Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration.
Endo K, Takino T, Miyamori H, Kinsen H, Yoshizaki T, Furukawa M, Sato H., J Biol Chem 278(42), 2003
PMID: 12904296
Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes.
Hotary KB, Yana I, Sabeh F, Li XY, Holmbeck K, Birkedal-Hansen H, Allen ED, Hiraoka N, Weiss SJ., J Exp Med 195(3), 2002
PMID: 11828004
Matrix metalloproteinase inhibitors: do they have a place in anticancer therapy?
Rudek MA, Venitz J, Figg WD., Pharmacotherapy 22(6), 2002
PMID: 12066962
How matrix metalloproteinases regulate cell behavior.
Sternlicht MD, Werb Z., Annu Rev Cell Dev Biol 17(), 2001
PMID: 11687497
Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.
Lang R, Kocourek A, Braun M, Tschesche H, Huber R, Bode W, Maskos K., J Mol Biol 312(4), 2001
PMID: 11575928

53 References

Daten bereitgestellt von Europe PubMed Central.

Matrix metalloproteinases: structures, evolution, and diversification.
Massova I, Kotra LP, Fridman R, Mobashery S., FASEB J. 12(12), 1998
PMID: 9737711
Matrix metalloproteinases.
Nagase H, Woessner JF Jr., J. Biol. Chem. 274(31), 1999
PMID: 10419448
Matrix metalloproteinases.
Johnson LL, Dyer R, Hupe DJ., Curr Opin Chem Biol 2(4), 1998
PMID: 9736919
Matrix metalloproteinases and diseases of the CNS.
Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR., Trends Neurosci. 21(2), 1998
PMID: 9498303
Matrix metalloproteinases and the development of cancer.
Coussens LM, Werb Z., Chem. Biol. 3(11), 1996
PMID: 8939708
Changing views of the role of matrix metalloproteinases in metastasis.
Chambers AF, Matrisian LM., J. Natl. Cancer Inst. 89(17), 1997
PMID: 9293916
Inactivation of human plasma alpha 1-proteinase inhibitor by human PMN leucocyte collagenase.
Knauper V, Reinke H, Tschesche H., FEBS Lett. 263(2), 1990
PMID: 2159425
Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins.
Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ., Cell 95(3), 1998
PMID: 9814707
Fibrinogen and fibrin.
Doolittle RF., Annu. Rev. Biochem. 53(), 1984
PMID: 6383194
Herrick S, Blanc-Brude O, Gray A, Laurent G., Int. J. Biochem. Cell Biol. 31(7), 1999
PMID: 10467729

The conversion of fibrinogen to fibrin: recombinant fibrinogen typifies plasma fibrinogen.
Gorkun OV, Veklich YI, Weisel JW, Lord ST., Blood 89(12), 1997
PMID: 9192765
"Normal" thrombin generation.
Butenas S, van't Veer C, Mann KG., Blood 94(7), 1999
PMID: 10498586

Mann, Thromb. Haemostasis 82(), 1999
Amino acid sequence of human beta-factor XIIa.
Fujikawa K, McMullen BA., J. Biol. Chem. 258(18), 1983
PMID: 6604055
Preparation of active recombinant TIMP-1 from Escherichia coli inclusion bodies and complex formation with the recombinant catalytic domain of PMNL-collagenase.
Kleine T, Bartsch S, Blaser J, Schnierer S, Triebel S, Valentin M, Gote T, Tschesche H., Biochemistry 32(51), 1993
PMID: 8260495
A 25 kDa alpha 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase.
Triebel S, Blaser J, Reinke H, Tschesche H., FEBS Lett. 314(3), 1992
PMID: 1281792
Purification of human collagenases with a hydroxamic acid affinity column.
Moore WM, Spilburg CA., Biochemistry 25(18), 1986
PMID: 3021211
Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas.
Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, Lopez-Otin C., J. Biol. Chem. 269(24), 1994
PMID: 8207000
Quantitative zymography: detection of picogram quantities of gelatinases.
Kleiner DE, Stetler-Stevenson WG., Anal. Biochem. 218(2), 1994
PMID: 8074288

Exposure of platelet fibrinogen receptors by ADP and epinephrine.
Bennett JS, Vilaire G., J. Clin. Invest. 64(5), 1979
PMID: 574143
Human platelets possess an inducible and saturable receptor specific for fibrinogen.
Marguerie GA, Plow EF, Edgington TS., J. Biol. Chem. 254(12), 1979
PMID: 447655

Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells.
Lewalle JM, Munaut C, Pichot B, Cataldo D, Baramova E, Foidart JM., J. Cell. Physiol. 165(3), 1995
PMID: 7593226


High levels of expression of collagenase-3 (MMP-13) in pathological conditions associated with a foreign-body reaction.
Imai S, Konttinen YT, Jumppanen M, Lindy O, Ceponis A, Kemppinen P, Sorsa T, Santavirta S, Xu JW, Lopez-Otin C., J Bone Joint Surg Br 80(4), 1998
PMID: 9699841
Matrix metalloproteinases generate angiostatin: effects on neovascularization.
Cornelius LA, Nehring LC, Harding E, Bolanowski M, Welgus HG, Kobayashi DK, Pierce RA, Shapiro SD., J. Immunol. 161(12), 1998
PMID: 9862716
Processing of tumour necrosis factor-alpha precursor by metalloproteinases.
Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL., Nature 370(6490), 1994
PMID: 8052310

Hertfelder, Eur. J. Clin. Chem. Biochem. 32(), 1994
Metalloproteinases and cancer invasion.
Liotta LA, Stetler-Stevenson WG., Semin. Cancer Biol. 1(2), 1990
PMID: 2103492

The role of the C-terminal domain in collagenase and stromelysin specificity.
Murphy G, Allan JA, Willenbrock F, Cockett MI, O'Connell JP, Docherty AJ., J. Biol. Chem. 267(14), 1992
PMID: 1315762
Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases.
d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G., Eur. J. Biochem. 250(3), 1997
PMID: 9461298


Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®


PMID: 10930399
PubMed | Europe PMC

Suchen in

Google Scholar